Lupin Q2 Results Live : Lupin declared their Q2 results on November 7, 2024, reporting a robust performance with a topline ...

Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...

North America Q2 sales were Rs 1,971.1 crore, up 5.6 percent compared to Rs 1,866.6 crore, accounting for 36 percent of Lupin ...

NHPC, Lupin, Mahindra & Mahindra, Rail Vikas Nigam Ltd., and Trent are set to release their Q2 earnings today, with strong ...

Macquarie analysts described the results as an "all-round beat". Although revenue aligned closely with their forecast, Ebitda ...

The focus is on the company's improved profitability in the US markets and its plans to expand its business with new products ...

Lupin receives US FDA tentative approval for raltegravir tablets, USP: Our Bureau, Mumbai Friday, November 8, 2024, 17:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...

Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and ...

Lupin’s average revenue will potentially increase 9.2 per cent Y-o-Y to Rs 5,502 crore as against Rs 5,038 crore in Q2FY24.

Lupin Limited delivered a strong financial performance for the second quarter, surpassing market expectations. Net profit for ...

Pharma major Lupin Ltd reported a robust 74.1% year-on-year rise in its consolidated net profit, reaching Rs 852.63 crore for ...